| Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate B Ettinger, SJ Martin, G Crans, I Pavo Journal of bone and mineral research 19 (5), 745-751, 2004 | 560 | 2004 |
| Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial S Del Prato, SE Kahn, I Pavo, GJ Weerakkody, Z Yang, J Doupis, ... The Lancet 398 (10313), 1811-1824, 2021 | 351 | 2021 |
| Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes I Pavo, G Jermendy, TT Varkonyi, Z Kerenyi, A Gyimesi, S Shoustov, ... The Journal of Clinical Endocrinology & Metabolism 88 (4), 1637-1645, 2003 | 240 | 2003 |
| Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy H Dobnig, A Sipos, Y Jiang, A Fahrleitner-Pammer, LG Ste-Marie, ... The Journal of Clinical Endocrinology & Metabolism 90 (7), 3970-3977, 2005 | 234 | 2005 |
| Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene … JA Kanis, O Johnell, DM Black, RW Downs Jr, S Sarkar, T Fuerst, ... Bone 33 (3), 293-300, 2003 | 223 | 2003 |
| Nuclear targeting of chlorin e6 enhances its photosensitizing activity TV Akhlynina, DA Jans, AA Rosenkranz, NV Statsyuk, IY Balashova, ... Journal of biological Chemistry 272 (33), 20328-20331, 1997 | 196 | 1997 |
| Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis JJ Stepan, DB Burr, I Pavo, A Sipos, D Michalska, J Li, ... Bone 41 (3), 378-385, 2007 | 192 | 2007 |
| Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis N Sattar, DK McGuire, I Pavo, GJ Weerakkody, H Nishiyama, RJ Wiese, ... Nature medicine 28 (3), 591-598, 2022 | 185 | 2022 |
| Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study O Johnell, JA Kanis, DM Black, A Balogh, G Poor, S Sarkar, C Zhou, ... Journal of Bone and Mineral Research 19 (5), 764-772, 2004 | 158 | 2004 |
| Role of flanking sequences and phosphorylation in the recognition of the simian-virus-40 large T-antigen nuclear localization sequences by importin-α MRM Fontes, T Teh, G Toth, A John, I Pavo, DA Jans, B Kobe Biochemical Journal 375 (2), 339-349, 2003 | 146 | 2003 |
| Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis P Chen, PD Miller, R Recker, H Resch, A Rana, I Pavo, AA Sipos Journal of Bone and Mineral Research 22 (8), 1173-1180, 2007 | 97 | 2007 |
| Raloxifene prevents the growth of uterine leiomyomas in premenopausal women S Jirecek, A Lee, I Pavo, G Crans, W Eppel, R Wenzl Fertility and sterility 81 (1), 132-136, 2004 | 97 | 2004 |
| Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial HJL Heerspink, N Sattar, I Pavo, A Haupt, KL Duffin, Z Yang, RJ Wiese, ... The Lancet Diabetes & Endocrinology 10 (11), 774-785, 2022 | 96 | 2022 |
| Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate H Dobnig, JJ Stepan, DB Burr, J Li, D Michalská, A Sipos, H Petto, ... Journal of Bone and Mineral Research 24 (12), 1998-2006, 2009 | 95 | 2009 |
| Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment YL Ma, QQ Zeng, AY Chiang, D Burr, J Li, H Dobnig, ... Bone 59, 139-147, 2014 | 93 | 2014 |
| Teriparatide in patients with osteoporosis and type 2 diabetes AV Schwartz, I Pavo, J Alam, DP Disch, D Schuster, JM Harris, JH Krege Bone 91, 152-158, 2016 | 87 | 2016 |
| Adenoviruses synergize with nuclear localization signals to enhance nuclear delivery and photodynamic action of internalizable conjugates containing chlorin e6 TV Akhlynina, DA Jans, NV Statsyuk, IY Balashova, G Toth, I Pavo, ... International journal of cancer 81 (5), 734-740, 1999 | 81 | 1999 |
| Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD … K Cusi, N Sattar, LE García‐Pérez, I Pavo, M Yu, KE Robertson, ... Diabetic Medicine 35 (10), 1434-1439, 2018 | 80 | 2018 |
| Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c B Gallwitz, S Dagogo‐Jack, V Thieu, LE Garcia‐Perez, I Pavo, M Yu, ... Diabetes, Obesity and Metabolism 20 (2), 409-418, 2018 | 73 | 2018 |
| Vitamin D and calcium supplementation for three years in postmenopausal osteoporosis significantly alters bone mineral and organic matrix quality EP Paschalis, S Gamsjaeger, N Hassler, A Fahrleitner-Pammer, H Dobnig, ... Bone 95, 41-46, 2017 | 71 | 2017 |
